40 Participants Needed

Controlled Diet for Kidney Stone Prevention

SF
Sonia Fargue Profile | University of ...
Overseen BySonia Fargue, M.D., Ph.D.
Age: 18 - 65
Sex: Any
Trial Phase: Academic
Sponsor: University of Alabama at Birmingham
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

There is increasing evidence that obesity is associated with increased urinary oxalate excretion, an important risk factor for calcium oxalate stone formation. By the administration of a controlled low oxalate diet the investigators will estimate endogenous oxalate synthesis in both non-obese and obese non-kidney-stone forming adults. This study seeks to thusly increase the understanding of the relationships between obesity and endogenous oxalate synthesis to serve as a platform to develop novel therapies for stone prevention.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

What data supports the effectiveness of the treatment Controlled Diet, Dietary Intervention, Nutritional Therapy for kidney stone prevention?

Research shows that dietary advice alone can reduce factors in urine that lead to kidney stones, and combining nutritional guidance with other therapies can help prevent stones from coming back.12345

Is a controlled diet for kidney stone prevention safe for humans?

Research shows that dietary changes, like those in the DASH diet, are generally safe and can reduce the risk of kidney stones. These diets emphasize fruits, vegetables, and low-fat dairy while limiting sodium and red meat, which are safe components for most people.15678

How is the Controlled Diet treatment for kidney stone prevention different from other treatments?

The Controlled Diet treatment for kidney stone prevention is unique because it focuses on personalized dietary changes to reduce stone risk, rather than relying solely on medication. This approach involves adjusting fluid intake, calcium, sodium, and animal protein in the diet, tailored to each individual's specific needs and stone risk factors.147910

Research Team

DA

Dean G Assimos, MD

Principal Investigator

University of Alabama at Birmingham

Eligibility Criteria

This trial is for adults aged 25-60 who are not obese (BMI <50) and have no history of kidney stones, diabetes, liver or renal diseases, bowel or other endocrine disorders. Pregnant women or those planning to become pregnant soon cannot participate.

Inclusion Criteria

Your Body Mass Index (BMI) is less than 50.
I am between 25 and 60 years old.

Exclusion Criteria

I have had kidney stones in the past.
I have a history of diabetes, liver, kidney, bowel diseases, or other hormone-related conditions.
My liver enzymes are abnormal.
See 2 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Dietary Intervention

Participants are placed on a controlled low oxalate diet to estimate endogenous oxalate synthesis

12 days
Daily monitoring

Assessment

Participants receive oral doses of 13C2-glycolate and 13C6-vitamin C to determine conversion to 13C2-oxalate and assess body morphometric indices, oxidative stress, and insulin resistance

Concurrent with dietary intervention

Follow-up

Participants are monitored for safety and effectiveness after the dietary intervention

4 weeks

Treatment Details

Interventions

  • Controlled Diet
Trial Overview The study is testing the impact of a controlled low oxalate diet on non-obese and obese individuals without kidney stones. The goal is to understand how obesity affects the body's production of oxalate, which could lead to new treatments for preventing kidney stones.
Participant Groups
6Treatment groups
Active Control
Group I: 20-24.9 BMIActive Control1 Intervention
Participants with a BMI that falls between 20 and 24.9 who will receive the controlled diet
Group II: 25-29.9 BMIActive Control1 Intervention
Participants with a BMI that falls between 25 and 29.9 who will receive the controlled diet
Group III: 30-34.9 BMIActive Control1 Intervention
Participants with a BMI that falls between 30 and 34.9 who will receive the controlled diet
Group IV: 35-39.9 BMIActive Control1 Intervention
Participants with a BMI that falls between 35 and 39.9 who will receive the controlled diet
Group V: 40-44.9 BMIActive Control1 Intervention
Participants with a BMI that falls between 40 and 44.9 who will receive the controlled diet
Group VI: 45-50 BMIActive Control1 Intervention
Participants with a BMI that falls between 45 and 50 who will receive the controlled diet.

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Alabama at Birmingham

Lead Sponsor

Trials
1,677
Recruited
2,458,000+

Findings from Research

A combined nutritional and medical therapy approach significantly improved urinary risk factors for stone disease in 137 patients over an average follow-up of 14.39 months, with notable improvements in hypocitraturia (67% of patients), hypercalciuria (82%), and hyperuricosuria (72%).
The study highlights that individualized medical management based on specific urinary abnormalities can effectively reduce stone risk, especially for patients who do not respond to dietary changes.
Patient-centered medical therapy for nephrolithiasis.Marchini, GS., Ortiz-Alvarado, O., Miyaoka, R., et al.[2013]
In a study of 242 patients with calcium-containing kidney stones, those who received specific dietary therapy tailored to their metabolic needs had a significantly lower recurrence rate of stones (6%) compared to those who followed general dietary advice (19%).
The results suggest that personalized dietary counseling is crucial for preventing future kidney stones, highlighting the importance of tailored interventions over generic recommendations.
A prospective study of nonmedical prophylaxis after a first kidney stone.Kocvara, R., Plasgura, P., Petrรญk, A., et al.[2019]
Dietary advice alone did not significantly reduce urinary supersaturation in most patients with idiopathic calcium urolithiasis, but it did lower calcium oxalate and uric acid supersaturation in 19% of patients who complied well with the recommendations.
Effective dietary management requires a balanced focus on both increasing fluid intake to over 2,000 ml/day and reducing meat protein intake, as these factors are interconnected and crucial for lowering the risk of stone formation.
Effects of a 'common sense diet' on urinary composition and supersaturation in patients with idiopathic calcium urolithiasis.Hess, B., Mauron, H., Ackermann, D., et al.[2018]

References

Patient-centered medical therapy for nephrolithiasis. [2013]
A prospective study of nonmedical prophylaxis after a first kidney stone. [2019]
Effects of a 'common sense diet' on urinary composition and supersaturation in patients with idiopathic calcium urolithiasis. [2018]
Influence of clinical therapy and nutritional counseling on the recurrence of urolithiasis. [2019]
Factors associated with patient recall of individualized dietary recommendations for kidney stone prevention. [2018]
DASH-style diet associates with reduced risk for kidney stones. [2022]
Diet and Stone Disease in 2022. [2022]
Adequate dietary intake and nutritional status in patients with nephrolithiasis: new targets and objectives. [2014]
Diet and alternative therapies in the management of stone disease. [2012]
Diet and Kidney Stones: The Ideal Questionnaire. [2022]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of ServiceยทPrivacy PolicyยทCookiesยทSecurity